Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis

@inproceedings{NgoGiangHuong2011ResistancePS,
  title={Resistance Patterns Selected by Nevirapine vs. Efavirenz in HIV-Infected Patients Failing First-Line Antiretroviral Treatment: A Bayesian Analysis},
  author={Nicole Ngo-Giang-Huong and Gonzague Jourdain and Billy Amzal and Pensiriwan Sang-a-gad and Rittha Lertkoonalak and Naree Eiamsirikit and Somboon Tansuphasawasdikul and Yuwadee Buranawanitchakorn and Naruepon Yutthakasemsunt and Sripetcharat Mekviwattanawong and Kenneth Mcintosh and Marc J Lallemant},
  booktitle={PloS one},
  year={2011}
}
BACKGROUND WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. Few studies have compared resistance patterns induced by efavirenz and nevirapine in patients infected with the CRF01_AE Southeast Asian HIV-subtype. We compared patterns of NNRTI- and NRTI-associated mutations in Thai adults failing first… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Ungass Country Progress Report Thailand

  • N Beerenwinkel, M Daumer, M Oette, K Korn, D Hoffmann
  • 2010

Similar Papers

Loading similar papers…